Stockley R A, O'Brien C, Pye A, Hill S L
Department of Respiratory Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
Chest. 2000 Jun;117(6):1638-45. doi: 10.1378/chest.117.6.1638.
To stratify COPD patients presenting with an acute exacerbation on the basis of sputum color and to relate this to the isolation and viable numbers of bacteria recovered on culture.
Open, longitudinal study of sputum characteristics and acute-phase proteins.
Patients presenting to primary-care physicians in the United Kingdom. Patients were followed up as outpatients in specialist clinic.
One hundred twenty-one patients with acute exacerbations of COPD were assessed together with a single sputum sample on the day of presentation (89 of whom produced a satisfactory sputum sample for analysis). One hundred nine patients were assessed 2 months later when they had returned to their stable clinical state.
The expectoration of green, purulent sputum was taken as the primary indication for antibiotic therapy, whereas white or clear sputum was not considered representative of a bacterial episode and the need for antibiotic therapy.
A positive bacterial culture was obtained from 84% of patients sputum if it was purulent on presentation compared with only 38% if it was mucoid (p < 0.0001). When restudied in the stable clinical state, the incidence of a positive bacterial culture was similar for both groups (38% and 41%, respectively). C-reactive protein concentrations were significantly raised (p < 0.0001) if the sputum was purulent (median, 4.5 mg/L; interquartile range [IQR], 6. 2 to 35.8). In the stable clinical state, sputum color improved significantly in the group who presented with purulent sputum from a median color number of 4.0 (IQR, 4.0 to 5.0) to 3.0 (IQR, 2.0 to 4. 0; p < 0.0001), and this was associated with a fall in median C-reactive protein level to 2.7 mg/L (IQR, 1.0 to 6.6; p < 0.0001).
The presence of green (purulent) sputum was 94.4% sensitive and 77.0% specific for the yield of a high bacterial load and indicates a clear subset of patient episodes identified at presentation that is likely to benefit most from antibiotic therapy. All patients who produced white (mucoid) sputum during the acute exacerbation improved without antibiotic therapy, and sputum characteristics remained the same even when the patients had returned to their stable clinical state.
根据痰液颜色对急性加重期慢性阻塞性肺疾病(COPD)患者进行分层,并将其与培养出的细菌分离及活菌数量相关联。
关于痰液特征和急性期蛋白的开放性纵向研究。
英国向基层医疗医生求诊的患者。患者在专科门诊接受门诊随访。
121例COPD急性加重期患者在就诊当天接受评估并采集一份痰液样本(其中89例患者提供了可用于分析的合格痰液样本)。109例患者在2个月后病情恢复至稳定临床状态时接受评估。
咳出绿色脓性痰液被视为抗生素治疗的主要指征,而白色或清亮痰液不被认为代表细菌感染发作及需要抗生素治疗。
就诊时痰液为脓性的患者中,84%痰培养细菌阳性,而黏液样痰液患者中仅38%痰培养细菌阳性(p<0.0001)。在稳定临床状态下再次研究时,两组细菌培养阳性率相似(分别为38%和41%)。如果痰液为脓性,C反应蛋白浓度显著升高(p<0.0001)(中位数为4.5mg/L;四分位间距[IQR]为6.2至35.8)。在稳定临床状态下,就诊时痰液为脓性的患者组中,痰液颜色从颜色中位数4.0(IQR为4.0至5.0)显著改善至3.0(IQR为2.0至4.0;p<0.0001),这与C反应蛋白水平中位数降至2.7mg/L(IQR为1.0至6.6;p<0.0001)相关。
绿色(脓性)痰液的存在对于高细菌载量培养结果的敏感性为94.4%,特异性为77.0%,表明就诊时确定的一个明确患者亚组可能从抗生素治疗中获益最大。所有在急性加重期咳出白色(黏液样)痰液的患者未经抗生素治疗病情均有改善,且即使患者恢复至稳定临床状态,痰液特征仍保持不变。